1. Home
  2. TEVA vs GFL Comparison

TEVA vs GFL Comparison

Compare TEVA & GFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TEVA
  • GFL
  • Stock Information
  • Founded
  • TEVA 1901
  • GFL 2007
  • Country
  • TEVA Israel
  • GFL Canada
  • Employees
  • TEVA N/A
  • GFL N/A
  • Industry
  • TEVA Biotechnology: Pharmaceutical Preparations
  • GFL
  • Sector
  • TEVA Health Care
  • GFL
  • Exchange
  • TEVA Nasdaq
  • GFL Nasdaq
  • Market Cap
  • TEVA 21.2B
  • GFL 17.5B
  • IPO Year
  • TEVA N/A
  • GFL 2020
  • Fundamental
  • Price
  • TEVA $18.95
  • GFL $47.91
  • Analyst Decision
  • TEVA Strong Buy
  • GFL Strong Buy
  • Analyst Count
  • TEVA 7
  • GFL 8
  • Target Price
  • TEVA $24.71
  • GFL $57.63
  • AVG Volume (30 Days)
  • TEVA 10.1M
  • GFL 1.1M
  • Earning Date
  • TEVA 11-05-2025
  • GFL 11-05-2025
  • Dividend Yield
  • TEVA N/A
  • GFL 0.12%
  • EPS Growth
  • TEVA N/A
  • GFL N/A
  • EPS
  • TEVA N/A
  • GFL 6.79
  • Revenue
  • TEVA $16,628,000,000.00
  • GFL $5,927,221,266.00
  • Revenue This Year
  • TEVA $4.07
  • GFL N/A
  • Revenue Next Year
  • TEVA $0.81
  • GFL $6.47
  • P/E Ratio
  • TEVA N/A
  • GFL $6.71
  • Revenue Growth
  • TEVA 2.08
  • GFL 19.12
  • 52 Week Low
  • TEVA $12.47
  • GFL $38.78
  • 52 Week High
  • TEVA $22.80
  • GFL $52.00
  • Technical
  • Relative Strength Index (RSI)
  • TEVA 66.51
  • GFL 38.23
  • Support Level
  • TEVA $17.89
  • GFL $49.11
  • Resistance Level
  • TEVA $18.96
  • GFL $50.10
  • Average True Range (ATR)
  • TEVA 0.52
  • GFL 0.80
  • MACD
  • TEVA 0.06
  • GFL -0.29
  • Stochastic Oscillator
  • TEVA 91.24
  • GFL 5.16

About TEVA Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.

About GFL GFL Environmental Inc. Subordinate voting shares no par value

GFL Environmental Inc is an environmental services company. Its offerings include non-hazardous solid waste management, infrastructure, soil remediation, and liquid waste management services. Its solid waste management business line, which generates the majority of the revenue, consists of the collection, transportation, transfer, recycling, and disposal of non-hazardous solid waste. Its Environmental Services business line includes liquid waste and soil remediation. The company's geographical segments are Canada and the United States. The company derives the majority of its revenue from the United States.

Share on Social Networks: